The risk is worth the big upwards potentialDid some fundamental DD and i see many upside potential in this stock over the long term. Why is this stock so cheap to begin with? The stock is undervalued and should be at 8-10 dollar range atm.
Now is a good time to buy. Every negative thing that can happen is already baked in the stock price. Not much to short anymore. When things don't work out, i don't see the stock go completely to 0. Geron doesn't have any debts. Biotech is however risky, don't put all your life savings into this company...
Best case scenario this stock can soar to triple digits with a lot of volatility. First target is 20 dollar.
For now, let's wait for the catalist we need. FDA approval will take probably a year at least. Best case scenario few months before the end of this year. This far the clinical results of imetelstat look promising.
